Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development. - sprookjes - yvandenbroek - TriplyDB

Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development.

Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development.

http://www.wikidata.org/entity/Q34173693

about

Brain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic pain Emerging targets in neuroinflammation-driven chronic pain Duloxetine Inhibits Microglial P2X4 Receptor Function and Alleviates Neuropathic Pain after Peripheral Nerve Injury P2X4 Receptor Function in the Nervous System and Current Breakthroughs in Pharmacology.Pathological pain and the neuroimmune interface.Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional roles Role of C-C chemokine receptor type 7 and its ligands during neuroinflammation Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide.Selective corticospinal tract injury in the rat induces primary afferent fiber sprouting in the spinal cord and hyperreflexia Real-time analysis of microglial activation and motility in hepatic and hyperammonemic encephalopathy.CCL-1 in the spinal cord contributes to neuropathic pain induced by nerve injury.The Expression of Inflammatory Mediators in Bladder Pain Syndrome Microglia during development and aging.Role of lipocalin-2-chemokine axis in the development of neuropathic pain following peripheral nerve injury P2X4R+ microglia drive neuropathic pain.Glia and pain: is chronic pain a gliopathy?Interleukin-1β pre-treated bone marrow stromal cells alleviate neuropathic pain through CCL7-mediated inhibition of microglial activation in the spinal cord.ATP receptors gate microglia signaling in neuropathic pain.P2X4 purinoceptor signaling in chronic pain.Chemokines in CNS injury and repair.Microglia and intractable chronic pain.Neurotransmitter signaling in the pathophysiology of microglia.Microglia control neuronal network excitability via BDNF signalling.P2X4 receptors and neuropathic pain.Inflammation in neurodegenerative diseases--an update.Calcium-permeable ion channels in pain signaling.Neuronal CC chemokines: the distinct roles of CCL21 and CCL2 in neuropathic pain.The purinergic system and glial cells: emerging costars in nociception.Central nervous system myeloid cells as drug targets: current status and translational challenges.P2Y12 receptors in primary microglia activate nuclear factor of activated T-cell signaling to induce C-C chemokine 3 expression.The therapeutic potential of targeting chemokine signalling in the treatment of chronic pain.Chemokines in neuron-glial cell interaction and pathogenesis of neuropathic pain.Purinergic signaling in microglia in the pathogenesis of neuropathic pain.P2X receptor-channels in chronic pain pathways.Polymorphisms in CAMKK2 may predict sensory neuropathy in African HIV patients.Sweepers in the CNS: Microglial Migration and Phagocytosis in the Alzheimer Disease Pathogenesis.Endoplasmic Reticulum Stress and Disrupted Neurogenesis in the Brain Are Associated with Cognitive Impairment and Depressive-Like Behavior after Spinal Cord Injury.Toll-like receptors and their role in persistent pain.Injured sensory neuron-derived CSF1 induces microglial proliferation and DAP12-dependent pain.Involvement of P2X4 receptors in hippocampal microglial activation after status epilepticus.

P2860

Q26995375-8237189F-4F29-49EB-874D-B61DAE508588 Q28242435-06704B56-8D98-4265-9CD8-927DEA938CBE Q28552863-9D210A7A-36CB-4A49-9CB9-64F33AEE3957 Q33718454-54A1A1E8-C571-49BC-88A7-2A1C44BE5921 Q33925677-5C8A6E65-A2E9-4F46-801E-16C0776C4BD0 Q34002086-3D1F7A66-F6DD-47F7-A2C5-9BCE4BB7BDAF Q36146400-4924A793-CFEB-4653-9F67-940F32E3712C Q36348374-576499FE-67D9-4CE3-AC82-111D62CA8403 Q36403532-4102272C-DC20-4EC3-BA62-5518CC29E2EF Q36670749-4AE0010D-1207-49B8-A32F-48F417B94886 Q36985101-6737135B-7BAA-4D97-9146-4D665553479D Q37051382-06C10B8D-6B26-4CF2-987A-516FFAC20E59 Q37080038-69B025D0-D8B2-453F-9C7F-F20B158AB140 Q37099774-0476C947-6A30-4F9D-A645-4C78BD62C6FA Q37256253-4DD88DF1-C881-4F97-B75F-A771C4AD524A Q37381399-C9C9D6EE-BAF3-4AA6-BB03-D1A8AF435CC5 Q37640194-A3737494-9AC3-491A-ACF5-3A43D88070DF Q37960756-6EDD038C-FA48-4037-9C80-0454573A3A0C Q38005032-90222D19-6C8B-47BE-B548-7347B226A8FF Q38018862-74D1942D-676A-44CD-9285-06D4655F4A90 Q38022210-00302C7C-BCAE-45E9-A139-FB0324C966FC Q38102686-860906F3-20FE-42DA-BE68-AB61148D58C1 Q38148753-6213BAA2-A411-49E0-8D5A-9E5EA2751E68 Q38160004-5EB51E88-0F3D-42A6-A0FB-06AB0AFE3A2C Q38170472-54DC4EA8-8694-4455-90BF-F9B253B9829D Q38175134-A91440A0-467C-4CBA-BD34-F006DB5081DA Q38242192-B52E9AAC-38E0-4EED-9282-57D0B53042AB Q38256177-289EC94C-3125-4FF5-AA61-C52C441ACAA6 Q38658658-F5E151EA-6E0F-491F-81A7-8D9CF6321756 Q38987628-41443B31-27B1-4FCC-B639-0A6B0493DCE1 Q39038441-233C7E3C-907C-4B7D-96A7-00030525E1E7 Q39227824-4BB2D2A4-7EF8-4AE7-A562-B1BB39904C79 Q39245180-B5EF186D-3DBA-4705-9959-2B63FFDE4134 Q39448037-EF59B568-AA02-4CB7-94EC-AB522280D696 Q40826704-F91FE9FB-9CF6-4DFB-8934-5411A908AE7B Q42177260-D05F8916-F33B-499D-B776-B49E400CFFC2 Q42740692-1F9FBD87-EEF6-4D62-84AD-E886E88D8821 Q43075865-9F849A49-AB56-469D-BF63-E4085EAFF011 Q43102822-23294697-12E5-46A3-8CAC-75AA123ED1B3 Q45841306-B0BCB74C-F66A-4722-B9D6-B3541E99C6E6

P2860

Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development.

http://www.wikidata.org/entity/Q34173693

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Neuronal CCL21 up-regulates mi ...... neuropathic pain development.

@ast

Neuronal CCL21 up-regulates mi ...... neuropathic pain development.

@en

Neuronal CCL21 up-regulates mi ...... neuropathic pain development.

@nl

type

label

Neuronal CCL21 up-regulates mi ...... neuropathic pain development.

@ast

Neuronal CCL21 up-regulates mi ...... neuropathic pain development.

@en

Neuronal CCL21 up-regulates mi ...... neuropathic pain development.

@nl

prefLabel

Neuronal CCL21 up-regulates mi ...... neuropathic pain development.

@ast

Neuronal CCL21 up-regulates mi ...... neuropathic pain development.

@en

Neuronal CCL21 up-regulates mi ...... neuropathic pain development.

@nl

P1433

Q34173693-4DC50E4B-F472-4616-B52F-76CB81FCD06C

P1476

Q34173693-50F37030-6BB7-4F7B-9C14-A1AF3C341796

P2093

Q34173693-1A5699AE-748B-45C0-A5E4-7E0F97906849

Q34173693-206AEDAD-2F3D-4CC8-9E04-6B5C2DB90568

Q34173693-21DA0FF3-CA0E-4C85-BD89-E02A5A69D425

Q34173693-8DF8860E-CCBE-4581-9676-856A3BC5DFEF

Q34173693-98736674-209E-4B54-88C5-9A2B4C2C18FC

Q34173693-FB9046E6-2831-41BE-9B5F-D86F05C32E2F

Q34173693-FD9B63B5-C345-4DBD-B21C-D3A51D9F0330

P2860

Q34173693-0119658A-E471-4848-8A2D-6D902ECDADFA

Q34173693-02C1575C-241F-4F6A-BB09-2343787D92D4

Q34173693-066DAA05-1824-4277-88A3-A5F9020A58FC

Q34173693-08DD1596-EC16-498E-8B78-B30D1BB11193

Q34173693-09EACA57-D817-4C5A-9E56-727767CB1569

Q34173693-0D4F4B8A-A317-462C-A81C-00F16601F89C

Q34173693-1371EA82-2C21-441D-9E9D-F8E900344C09

Q34173693-139DDC92-7FD4-448A-9A67-F8173403FC65

Q34173693-18DD1AD5-7EEC-43B3-A17D-D69AC7B4954E

Q34173693-1C3BE5EB-1E60-4686-9F6E-8121910E5913

P304

Q34173693-47B48FE0-1B6B-4E8B-BC11-B5EC9DA5AEF4

P31

Q34173693-720E6E53-9283-4C79-AE67-FE3976A905BA

P356

Q34173693-22D8FC67-79DF-4B3C-90DD-03C36D1C802D

P407

Q34173693-25CE5D78-0730-4C02-A451-5985582E3AA3

P433

Q34173693-7411D158-FB2E-432A-BD5F-55757D395E73

P478

Q34173693-7195A5AF-FD15-4ED2-82F0-6D0889759DC5

P50

Q34173693-9D444EBA-AADA-422B-8BAE-B9AF9A84983E

P577

Q34173693-4CCBA4DA-7E5D-49CC-8A35-B5398183964D

P5875

Q34173693-BF7750BF-23CA-48A5-9A1E-74255EB87656

P698

Q34173693-59A40075-2852-41E1-AFBC-BCB1F6B55996

P921

Q34173693-6A0276BE-185F-4ADD-91CE-B9D4CDA518AF

Q34173693-B4D215A6-A812-4EF1-B4F9-7DED2B5FAE7D

P932

Q34173693-58E587D3-97C0-4F79-9D8E-99997B745E06

P356

P1433

The EMBO Journal

P1476

Neuronal CCL21 up-regulates mi ...... s neuropathic pain development

@en

P2093

Emika Toyomitsu

http://www.w3.org/2001/XMLSchema#string

Hendrikus Boddeke

http://www.w3.org/2001/XMLSchema#string

Hidetoshi Tozaki-Saitoh

http://www.w3.org/2001/XMLSchema#string

Kazuhide Inoue

http://www.w3.org/2001/XMLSchema#string

Keiko Tsukamoto

http://www.w3.org/2001/XMLSchema#string

Knut Biber

http://www.w3.org/2001/XMLSchema#string

Makoto Tsuda

http://www.w3.org/2001/XMLSchema#string

P2860

Behavioral phenotypes of mice lacking purinergic P2X4 receptors in acute and chronic pain assays

Chemokines and the pathophysiology of neuropathic pain

P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury

Challenge with innate and protein antigens induces CCR7 expression by microglia in vitro and in vivo

Control of microglial neurotoxicity by the fractalkine receptor

Lyn tyrosine kinase is required for P2X(4) receptor upregulation and neuropathic pain after peripheral nerve injury

The P2Y12 receptor regulates microglial activation by extracellular nucleotides

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

ATP mediates rapid microglial response to local brain injury in vivo

BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain

P304

1864-1873

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/EMBOJ.2011.89

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Takahiro Masuda

P577

2011-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50868336

http://www.w3.org/2001/XMLSchema#string

P698

21441897

http://www.w3.org/2001/XMLSchema#string

P921

neuropathic pain

P932

3101996

http://www.w3.org/2001/XMLSchema#string